These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22546752)

  • 41. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Anania C; Martino F; Cantisani V; Pascone R; Marcantonio A; Chiesa C
    Hepatology; 2010 Nov; 52(5):1643-51. PubMed ID: 20890890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.
    Oh HJ; Kim TH; Sohn YW; Kim YS; Oh YR; Cho EY; Shim SY; Shin SR; Han AL; Yoon SJ; Kim HC
    Korean J Hepatol; 2011 Mar; 17(1):27-36. PubMed ID: 21494075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.
    Kozakova M; Palombo C; Eng MP; Dekker J; Flyvbjerg A; Mitrakou A; Gastaldelli A; Ferrannini E;
    Hepatology; 2012 May; 55(5):1406-15. PubMed ID: 22334565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
    Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.
    Bedogni G; Bellentani S; Miglioli L; Masutti F; Passalacqua M; Castiglione A; Tiribelli C
    BMC Gastroenterol; 2006 Nov; 6():33. PubMed ID: 17081293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study.
    Cicero AF; D'Addato S; Reggi A; Marchesini G; Borghi C;
    Metab Syndr Relat Disord; 2013 Dec; 11(6):412-6. PubMed ID: 23902132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
    Alper AT; Hasdemir H; Sahin S; Ontürk E; Akyol A; Nurkalem Z; Cakmak N; Erdinler I; Gürkan K
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):376-81. PubMed ID: 19155640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.
    de Piano A; Tock L; Carnier J; Oyama LM; Oller do Nascimento CM; Martinz AC; Foschini D; Sanches PL; Ernandes RM; de Mello MT; Tufik S; Dâmaso AR
    Metabolism; 2010 May; 59(5):613-9. PubMed ID: 19942238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents.
    Huang RC; Beilin LJ; Ayonrinde O; Mori TA; Olynyk JK; Burrows S; Hands B; Adams LA
    Hepatology; 2013 Oct; 58(4):1306-14. PubMed ID: 23703776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
    Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
    Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated liver enzymes in metabolic syndrome are associated with coronary stenosis in a Tunisian population.
    Rejeb J; Omezzine A; Boumaiza I; Rebhi L; Kaouthar K; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
    Metab Syndr Relat Disord; 2010 Jun; 8(3):249-54. PubMed ID: 20156075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.